research use only

Fluorescein Dyes inhibitor

Cat.No.S5488

Fluorescein (Solvent Yellow 94, Resorcinolphthalein, Yellow fluorescein) is a manufactured organic compound and dye.
Fluorescein Dyes inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 332.31

Quality Control

Batch: S548801 DMSO]67 mg/mL]false]]]false]]]false Purity: 98%
98

Chemical Information, Storage & Stability

Molecular Weight 332.31 Formula

C20H12O5

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 2321-07-5 -- Storage of Stock Solutions

Synonyms Solvent Yellow 94, Resorcinolphthalein, Yellow fluorescein Smiles C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O

Solubility

In vitro
Batch:

DMSO : 67 mg/mL (201.61 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06375343 Not yet recruiting
Dry Eye Disease|Dry Eye Sensation|Ocular Surface Disease
Laboratorios Sophia S.A de C.V.
October 30 2024 Phase 1
NCT06379685 Not yet recruiting
Dry Eye|Dry Eyes Chronic|Dry Eye Syndromes
Laboratorios Sophia S.A de C.V.
September 30 2024 Phase 1
NCT06054178 Not yet recruiting
Pleomorphic Adenoma of the Parotid|Warthin Tumor|Head and Neck Disorder
Stanford University
May 2024 Phase 2
NCT06381986 Not yet recruiting
Corneal Erosion
Sunhawk Vision Biotech Inc.
May 2024 Phase 2
NCT06352541 Not yet recruiting
Healthy
Laboratorios Sophia S.A de C.V.
May 30 2024 Phase 1
NCT06163989 Not yet recruiting
Dry Eye Syndromes|Computer Vision Syndrome
Aston University
May 1 2024 Not Applicable

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.